Association of increased triglyceride levels in metabolic syndrome with coronary artery disease

Pakistan Journal of Medical Sciences

Volumn 26, Issue 3, 2010, Pages 667-672

  Helvaci, Mehmet Rami ^a   Kaya, Hasan ^a   Gundogdu, Mehmet ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

Metabolic syndrome; Triglyceride; White coat hypertension

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; AGED; AGING; ARTICLE; BODY MASS; BODY WEIGHT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL STRESS; PREVALENCE; SMOKING; STROKE; WHITE COAT HYPERTENSION;

EID: 77957337724     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
3. Tonkin AM. The metabolic syndrome(s)? Curr Atheroscler Rep 2004;6:165-166.
4. Franklin SS, Barboza MG, Pio JR, Wong ND. Blood pressure categories, hypertensive subtypes, and the metabolic syndrome. J Hypertens 2006;24:2009-2016.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evalua-tion, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;17:106:3143-3421.
6. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1333-1445.
7. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation 1999.
8. Helvaci MR, Kaya H, Borazan A, Ozer C, Seyhanli M, Yalcin A. Metformin and parameters of physical health. Intern Med 2008;47:697-703.
9. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821-848.
10. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251-1257.
11. Helvaci MR, Kaya H, Seyhanli M, Yalcin A. White coat hypertension in definition of metabolic syndrome. Int Heart J 2008;49:449-457.
12. Helvaci MR, Kaya H, Sevinc A, Camci C. Body weight and white coat hypertension. Pak J Med Sci 2009;25:6:916-921.
13. Mule G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, et al. Metabolic syndrome in subjects with white-coat hypertension: Impact on left ventricular structure and function. J Hum Hypertens 2007;21:854-860.
14. Helvaci MR, Seyhanli M. What a high prevalence of white coat hypertension in society! Intern Med 2006;45:671-674.
15. Hozawa A, Ohkubo T, Kikuya M, Yamaguchi J, Ohmori K, Fujiwara T, et al. Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: The Ohasama study. Hypertens Res 2002;25:57-63.
16. Celis H, Fagard RH. White-coat hypertension: A clinical review. Eur J Intern Med 2004;15:348-357.
17. Helvaci MR, Kaya H, Duru M, Yalcin A. What is the relationship between white coat hypertension and dyslipidemia? Int Heart J 2008;49:87-93.
18. Helvaci MR, Kaya H, Seyhanli M, Cosar E. White Coat Hypertension Is Associated with a Greater All-cause Mortality. J Health Sci 2007;53:156-160.
19. Bjorklund K, Lind L, Vessby B, Andrén B, Lithell H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: A population-based study of elderly men. Circulation 2002;106:63-68.
20. Di Angelantonia E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000.
21. Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonia E, Boekholdt SM, et al. Triglyceride- mediated pathways and coronary disease: Collabora- tive analysis of 101 studies. Lancet 2010;375:1634-1639.
22. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007;115:450-458.